Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma

Cancer

Volumn 85, Issue 8, 1999, Pages 1734-1739

  Wang, Xi ^a   Christiani, David C ^a,b   Mark, Eugene J ^b   Nelson, Heather ^a   Wiencke, John K ^c   Gunn, Laura ^a   Wain, John C ^b   Kelsey, Karl T ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asbestos; Cigarette smoking; K ras; Lung carcinoma; P53; Synchronous multiple primary tumors

Indexed keywords

ASBESTOS; PROTEIN P53;

ADULT; ARTICLE; CANCER SURVIVAL; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; ONCOGENE K RAS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME;

ADENOCARCINOMA; AGED; ASBESTOS; CARCINOGENS, ENVIRONMENTAL; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; COCARCINOGENESIS; DNA, NEOPLASM; ENVIRONMENTAL EXPOSURE; EXONS; FEMALE; GENES, P53; GENES, RAS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREVALENCE; SMOKING; SMOKING CESSATION;

EID: 0033561055     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990415)85:8<1734::AID-CNCR13>3.0.CO;2-1     Document Type: Article

References (30)

1. Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer 1932;16:1358-14.
2. Ichinosr Y, Hara N, Ohta M. Synchronous lung cancers defined by deoxyribonucleic acid flow cytometry. J Thorac Cardiovasc Surg 1991;102:418-24.
3. Noguchi M, Maezawa N, Nakanishi Y, Matsuno Y, Shimosato Y, Hirohashi S. Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas. Diagn Mol Pathol 1993;2:29-35.
4. Sozzi G, Miozzo M, Pastorino U, Pilotti S, Donghi R, Giarola M, et al. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res 1995;55:135-40.
5. Ferguson MK. Synchronous primary lung cancers. Chest 1993;103:398S-400S.
6. Carey FA, Donnelly SC, Walker WS, Cameron EWJ, Lamb D. Synchronous primary lung cancers: prevalence in surgical material and clinical implications. Thorax 1993;48:344-6.
7. Ribet M, Dambron P. Multiple primary lung cancers. Eur J Cardio-Thorac Surg 1995;9:231-6.
8. Antakii T, Schaefer RF, Rutherford JE, Read RC. Second primary lung cancer. Ann Thorac Surg 1995;59:863-6.
9. Kono M, Fujii M, Adachi S, Tanaka K, Shimizu T, Hirota S. Multiple primary lung cancers: radiographic and bronchoscopic diagnosis. J Thorac Imaging 1993;8:63-8.
10. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Cancer 1953;6: 963-8.
11. Moore C. Cigarette smoking and cancer of the mouth, pharynx, and larynx. JAMA 1971;218:553-8.
12. Wynder EL, Mushinski MH, Spivak JC. Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer 1977;40:1872-8.
13. Castigliano SG. Influence of continued smoking on the incidence of second primary cancers involving mouth, pharynx, and larynx. J Am Dent Assoc 1968;77:580-5.
14. Shottenfeld D, Gantt RC, Wumder EL. The role of alcohol and tobacco in multiple primary cancers of the upper digestive system, larynx and lung: a prospective study. Prev Med 1974;3:277-93.
15. Hsu TC, Spitz MR, Schantz SP. Mutagen sensitivity: a biologic marker of cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1991;1:83-9.
16. Verhagen AF, Tavilla G, van den Wal HJ, Cox AL, Lacquet LK. Multiple primary lung cancers. Thorac Cardiovasc Surg 1994;42:40-4.
17. Sturgis EM, Robert H, Miller RH. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 1995;104:946-54.
18. Bosari S, Viale G. The clinical significance of p53 aberrations in human tumors. Virchow's Arch 1995;427:229-41.
19. Slebos RJC, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJ, et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990; 323:561-5.
20. Banerjee SK, Makdisi WF, Weston AP, Mitchell SM, Campbell DR. Microwave-based DNA extraction from paraffin-embedded tissue for PCR amplification. Biotechniques 1995; 18:768-71.
21. Wang X, Christiani DC, Wiencke JK, Fischbein M, Xu X, Cheng TJ, et al. Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure. Cancer Epidemiol Biomarkers Prev 1995;4:543-8.
22. Toguchida K, Yamaguchi T, Richie B, et al. Mutation spectrum of the p53 gene in bone and soft tissue sarcoma. Cancer Res 1992;52:6194-9.
23. Harpole DH, Marks JR, Richards WG, Herndon JE, Sugarbaker DE. Localized adenocarcinoma of the lung: oncogene expression of erb-2 and p53 in 150 patients. Clin Cancer Res 1995;1:659-64.
24. Mitsudomi T, Steinberg SM, Oie HK, Mulshine JL, Phelps R, Viallet J, et al. Ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res 1991;51:4999-5002.
25. Cheng TJ, Christiani DC, Xu X, Wain JC, Wiencke JK, Kelsey KT. Glutathione S-transferase μ genotype, diet, and smoking as determinents of sister chromatid exchange frequency in lymphocytes. Cancer Epidemiol Biomarkers Prev 1995;4: 535-42.
26. McElvaney G, Miller RR, Muller NL, Nelems B, Evals KGL, Ostrow DN. Multicentricity of adenocarcinoma of the lung. Chest 1989;95:151-4.
27. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire D, Mnna JD, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 1995;7:558-63.
28. Nees M, Homann N, Discher H, Andl T, Enders C, Herold-Mende C, et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res 1993;53:4189-96.
29. Sozzi G, Miozzo M, Tagliabue E, Calderone C, Lombardi L, Pilotti S, et al. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res 1991;51:400-4.
30. Kawajiri K, Eguchi H, Nakachi K, Sekiya T, Yamamoto M. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res 1996;56: 72-6.